Document is current

Article History

Received: 16 February 2024

Accepted: 14 January 2025

First Online: 27 January 2025

Declarations

:

: The RADAR-AD was ethically approved in each participating country and aligns with the Helsinki Declaration of 1975, revised in 2008. All participants and their informants provided written informed consent prior to any study procedures.

: Authors AA, AKB, AM, CH, DR, GF, GW, HF, IL, LH, MGk, MGr, ML, MTG, PC, SN, VA, and VN declare no financial or non-financial competing interests. DA has received research support and/ or honoraria from Astra-Zeneca, H. Lundbeck, Novartis Pharmaceuticals, Evonik, Roche Diagnostics, and GE Health, and served as paid consultant for H. Lundbeck, Eisai, Heptares, Mentis Cura, Eli Lilly, Cognetivity, Enterin, Acadia, EIP Pharma, and Biogen. JC is an employee and a shareholder of Novartis. GS is an employee of Novartis. NC is employed by Novartis Pharma AG, Basel, Switzerland. Research of Alzheimer center Amsterdam (MM, CB) is part of the neurodegeneration research program of Amsterdam Neuroscience. Alzheimer Center Amsterdam is supported by Stichting Alzheimer Nederland and Stichting Steun Alzheimercentrum Amsterdam. MB is an employee of the Ace Alzheimer Center and an advisory board member for Grifols, Roche, Eli Lilly, Araclon Biotech, Merck, Zambon, Biogen, Novo Nordisk, Bioiberica, Eisai, Servier, and Schwabe Pharma. SG declares support for this work through the Italian Ministry of Health (Ricerca Corrente). GW and SV are employees and shareholders of Johnson & Johnson.